title: Percentage of urinary albumin excretion and serum-free light-chain reduction are important determinants of renal response in myeloma patients with moderate to severe renal impairment.
abstract: Reversal of renal dysfunction significantly affects the prognosis of multiple myeloma (MM) with renal impairment (RI). There is no reliable test for predicting reversibility of RI in MM patients. We postulated that MM with high albuminuria may reflect glomerular disease that is difficult to reverse. Here, we examined the impact of urinary albumin excretion. We retrospectively analyzed 279 patients admitted to our hospital from April 2000 to December 2013. Clinical variables and laboratory data that may affect myeloma treatment response were extracted. The results were examined for relationship to renal response by univariate and multivariate analysis. RI (estimated glomerular filtration rate ≦50 ml/min per 1.73 m(2)) was observed in 116 patients (46%) and renal responses of renal complete response, renal partial response, renal minor response and no response were obtained in 46 (40%), 15 (13%), 13 (11%) and 42 (36%) patients, respectively. Although renal recovery was significantly associated with Durie-Salmon 1 or 2 (P=0.02), myeloma response better than very good partial response (P=0.03), involved free light-chain (iFLC) reduction from baseline 80% at day 12 (P=0.005), ≧95% at day 21 (P<0.001) and urinary albumin ≦25% on admission (P<0.001) on univariate analysis, only reduction of iFLC 95% at day 21 (P=0.015) and urinary albumin ≦25% (P=0.007) remained significant for any renal response. Our observation indicates that increased urinary albumin excretion >25% and reduction of iFLC ≦95% on day 21 were associated with favorable renal recovery in MM patients with RI, and were considered as negative predictors for renal response.
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Chiba, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Sugihara
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Chiba, Japan.
authors.forename: D
authors.initials: D
authors.lastname: Chihara
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Chiba, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Seike
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Chiba, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Fukumoto
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Chiba, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Fujisawaa
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Chiba, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Suehara
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Chiba, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Nishida
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Chiba, Japan.
authors.forename: M
authors.identifier: 0000000185210098
authors.initials: M
authors.lastname: Takeuchi
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Chiba, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Matsue
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000419:Albuminuria / Q000097:blood / Q000401:mortality / Q000652:urine; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000097:blood*; D007674:Kidney Diseases / Q000097:blood / Q000401:mortality / Q000652:urine; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000401:mortality / Q000652:urine; D012189:Retrospective Studies; D015996:Survival Rate
chemical_list: D007147:Immunoglobulin Light Chains
references.citation: Leukemia. 2009 Jun;23(6):1152-7
references.pmid: 19225533
references.citation: Nephrol Dial Transplant. 2012 Mar;27(3):1097-101
references.pmid: 22067518
references.citation: Blood. 2010 Sep 2;116(9):1397-404
references.pmid: 20462963
references.citation: Kidney Int. 2005 Jun;67(6):2089-100
references.pmid: 15882252
references.citation: Nat Rev Nephrol. 2012 Feb 21;8(4):234-43
references.pmid: 22349488
references.citation: Expert Rev Hematol. 2012 Feb;5(1):51-66; quiz 67-8
references.pmid: 22272706
references.citation: Leuk Lymphoma. 1998 Aug;30(5-6):493-501
references.pmid: 9711912
references.citation: Blood. 2007 Mar 15;109(6):2604-6
references.pmid: 17138816
references.citation: Nephrol Dial Transplant. 2010 Apr;25(4):1340-3
references.pmid: 20061318
references.citation: Nephrol Dial Transplant. 2012 Oct;27(10):3823-8
references.pmid: 22273664
references.citation: J Clin Oncol. 2005 Dec 20;23(36):9219-26
references.pmid: 16275935
references.citation: Leukemia. 2006 Sep;20(9):1467-73
references.pmid: 16855634
references.citation: Eur J Haematol. 2000 Sep;65(3):175-81
references.pmid: 11007053
references.citation: Kidney Int. 2008 Jun;73(11):1282-8
references.pmid: 18385667
references.citation: Epidemiology. 2005 Jan;16(1):73-81
references.pmid: 15613948
references.citation: Mayo Clin Proc. 2003 Jan;78(1):21-33
references.pmid: 12528874
references.citation: Ann Intern Med. 2005 Dec 6;143(11):777-84
references.pmid: 16330788
references.citation: Leukemia. 2013 Feb;27(2):423-9
references.pmid: 22763386
references.citation: J Clin Oncol. 2010 Nov 20;28(33):4976-84
references.pmid: 20956629
references.citation: J Clin Oncol. 2009 Dec 20;27(36):6086-93
references.pmid: 19858394
references.citation: Ann Hematol. 2010 Mar;89(3):291-7
references.pmid: 19693498
references.citation: Clin J Am Soc Nephrol. 2009 Apr;4(4):745-54
references.pmid: 19339414
references.citation: N Engl J Med. 2011 Jun 16;364(24):2365-6
references.pmid: 21675906
references.citation: Nephrol Dial Transplant. 2012 Oct;27(10):3713-8
references.pmid: 23114897
references.citation: Nephrol Dial Transplant. 2011 Sep;26(9):2877-84
references.pmid: 21427073
references.citation: Clin J Am Soc Nephrol. 2012 Dec;7(12):1964-8
references.pmid: 23024162
references.citation: J Am Soc Nephrol. 2011 Jun;22(6):1129-36
references.pmid: 21511832
references.citation: Am J Kidney Dis. 2012 Jun;59(6):786-94
references.pmid: 22417785
references.citation: Blood. 2011 Nov 24;118(22):5759-66
references.pmid: 21951682
references.citation: Clin J Am Soc Nephrol. 2013 Nov;8(11):2007-17
references.pmid: 23868898
references.citation: Blood. 2013 Nov 21;122(22):3583-90
references.pmid: 24108460